Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma

被引:0
|
作者
Xiaoqing Ma
Zilin Deng
Zhen Li
Ting Ma
Guiqing Li
Cuijia Zhang
Wentao Zhang
Jin Chang
机构
[1] The Second Affiliated Hospital of Shandong First Medical University,Department of Radiation Oncology
[2] Shandong First Medical University,undefined
来源
关键词
Disulfidptosis; Ferroptosis; LUAD; Prognosis; Signature;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
    Ma, Xiaoqing
    Deng, Zilin
    Li, Zhen
    Ma, Ting
    Li, Guiqing
    Zhang, Cuijia
    Zhang, Wentao
    Chang, Jin
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [2] Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
    Zhao, Yi
    Wei, Yanjun
    Fan, Lingjia
    Nie, Yuanliu
    Li, Jianan
    Zeng, Renya
    Li, Jixian
    Zhan, Xiang
    Lei, Lingli
    Kang, Zhichao
    Li, Jiaxin
    Zhang, Wentao
    Yang, Zhe
    MOLECULAR MEDICINE, 2023, 29 (01)
  • [3] Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
    Yi Zhao
    Yanjun Wei
    Lingjia Fan
    Yuanliu Nie
    Jianan Li
    Renya Zeng
    Jixian Li
    Xiang Zhan
    Lingli Lei
    Zhichao Kang
    Jiaxin Li
    Wentao Zhang
    Zhe Yang
    Molecular Medicine, 29
  • [4] A novel prognostic model among ferroptosis, cuproptosis, and disulfidptosis in predicting prognosis of lung adenocarcinoma
    Sun, Jingyang
    Guan, Chungen
    Zhu, Zijiang
    Wang, Xintong
    ASIAN JOURNAL OF SURGERY, 2024, 47 (09) : 4197 - 4199
  • [5] Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis
    Cheng, Tao
    Shan, Guangyao
    Yang, Huiqin
    Gu, Jie
    Lu, Chunlai
    Xu, Fengkai
    Ge, Di
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Identifying and evaluating a disulfidptosis-related gene signature to predict prognosis in colorectal adenocarcinoma patients
    Li, Ming
    Wang, Jin
    Zhao, Yuhao
    Lin, Changjie
    Miao, Jianqing
    Ma, Xiaoming
    Ye, Zhenyu
    Chen, Chao
    Tao, Ke
    Zhu, Pengcheng
    Hu, Qi
    Sun, Jinbing
    Gu, Jianfeng
    Wei, Shaohua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA
    Wang, Ke
    Liu, Ying
    Lu, Guanzhong
    Xiao, Jinrong
    Huang, Jiao
    Lei, Lin
    Peng, Ji
    Li, Yangkai
    Wei, Sheng
    CANCER MEDICINE, 2022, 11 (01): : 281 - 294
  • [8] Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
    Li, Zhaodong
    Qi, Fangyuan
    Li, Fan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 20
  • [9] Characterization and Prognosis of Biological Microenvironment in Lung Adenocarcinoma through a Disulfidptosis-Related lncRNAs Signature
    Yang, Zhuo
    Cao, Shenglan
    Wang, Fangli
    Du, Kangming
    Hu, Fang
    GENETICS RESEARCH, 2023, 2023
  • [10] Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma
    Di Chen
    Qiaoqiao Li
    Yuan Xu
    Yanfei Wei
    Jianguo Li
    Xuqiang Zhu
    Hongjiang Li
    Yan Lu
    Xianzhi Liu
    Dongming Yan
    Cancer Cell International, 23